Shukra Pharmaceuticals Ltd — Others, 05-04-2025: Compliance certificate under Reg. 74(5) of SEBI (DP) reg.2018 for the quarter ended 31.03.2025.

Shukra Pharmaceuticals Ltd. has announced a board meeting aimed at addressing various corporate matters. In relation to dematerialization for the quarter ended March 31, 2025, the company confirmed that securities received from depository participants were duly processed and listed on the stock exchanges. This update underscores the company's effective management of its shareholders' securities and reflects a commitment to maintaining robust corporate governance. Investors may view this as a positive outlook, indicating the company’s dedication to transparency and operational efficiency.